ABOS

Q: What is the price of Acumen Pharmaceuticals Inc (ABOS) today?

The price of Acumen Pharmaceuticals Inc (ABOS) today is $ 2.14, with return of 5.42% compared to the last year. The price of Acumen Pharmaceuticals Inc (ABOS) started the year trading around $ 1.72 and today it is at $ 2.14. Follow the real-time price chart, the historical price of Acumen Pharmaceuticals Inc (ABOS) and international markets.

Q: When does Acumen Pharmaceuticals Inc (ABOS) pay dividends?

Acumen Pharmaceuticals Inc (ABOS) did not distribute dividends in the last year.

Q: Is Acumen Pharmaceuticals Inc (ABOS) worth it?

Currently, Acumen Pharmaceuticals Inc (ABOS) is priced at $ 2.14, with a P/E of -0.85%, representing a deviation of -38% from its historical average P/E. In the last year, the stock showed a variation of 5.42 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 5.42%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Acumen Pharmaceuticals Inc (ABOS) stock?

Investing in stocks of Acumen Pharmaceuticals Inc (ABOS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Acumen Pharmaceuticals Inc (ABOS) yield today?

The yield of Acumen Pharmaceuticals Inc (ABOS) was 18.23% in the last month, 5.42% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Acumen Pharmaceuticals Inc (ABOS) today, the total investment would be $ 214.00, based on the current price of $ 2.14.If past performance were to repeat, the return on your investment would be:In 1 year: $ 225.60In 5 years: $ 214.00In 10 years: $ 214.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Acumen Pharmaceuticals Inc

Price

$ 2.14

return (12m)

5.42%

p/e

-0.85

p/bv

1.22

DIVIDEND YIELD

0.00%

price ABOS

ABOS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ABOS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

18.23%

3 months

62.12%

1 year

5.42%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ABOS

review the fundamentals of Acumen Pharmaceuticals Inc shares

P/E

-0.85

Sector: 7.58 Industry: 7.58

P/SALES RATIO (PSR)

Sector: 2.24 Industry: 2.24

P/BV

1.22

Sector: 1.93 Industry: 1.93

DIVIDEND YIELD (DY)

0.00%

Sector: 0.67% Industry: 0.67%

ROA

-93.76%

Sector: -0.78% Industry: -0.78%

ROE

-143.13%

Sector: 3.80% Industry: 3.80%

ROIC

-480.12%

Sector: -131.19% Industry: -131.19%

NET MARGIN

0.00%

Sector: 1.44% Industry: 1.44%

GROSS MARGIN

0.00%

Sector: 30.26% Industry: 30.26%

OPERATING MARGIN

0.00%

Sector: 3.25% Industry: 3.25%

P/EBITDA

-0.88

Sector: 2.22 Industry: 2.22

P/EBIT

-0.88

Sector: 0.24 Industry: 0.24

P/ASSET

0.80

Sector: 0.96 Industry: 0.96

BVPS

1.53

Sector: 9.05 Industry: 9.05

EPS

-2.19

Sector: 0.57 Industry: 0.57

EQUITY RATIO

0.66

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

78.66%

Sector: - Industry: -

Fundamentals ABOS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	28.96	8.73	30.16%	0.31%	$ 1.69 T	30.89%
INTR	16.93	1.98	11.72%	0.97%	$ 3.63 B	15.47%
PBR	5.60	0.98	17.47%	16.22%	$ 78.17 B	16.15%
PLTR	394.43	64.60	16.38%	0.00%	$ 432.04 B	28.11%
VALE	10.01	1.30	13.01%	5.56%	$ 55.07 B	14.68%
SHEL	14.59	1.20	8.23%	3.88%	$ 213.41 B	5.44%
BDORY	10.26	0.66	6.40%	7.40%	$ 22.89 B	8.83%
STLA	2.97	0.41	13.77%	5.93%	$ 34.74 B	3.32%
MAIN	10.19	1.86	18.28%	6.95%	$ 5.47 B	86.13%
ENB	24.38	2.13	8.74%	5.61%	$ 104.88 B	9.40%
NSRGY	10.11	7.04	69.57%	3.48%	$ 251.33 B	11.75%
BBSEY	7.84	5.18	66.11%	11.79%	$ 12.44 B	100.00%
UNH	17.04	2.83	16.62%	2.60%	$ 299.80 B	4.04%
SAN	11.02	1.30	11.76%	1.92%	$ 167.13 B	22.61%
ITUB	10.53	1.94	18.42%	6.69%	$ 81.23 B	27.84%
TTE	10.21	1.23	12.05%	5.36%	$ 144.68 B	7.72%
PBR-A	5.19	0.91	17.47%	13.44%	$ 72.44 B	16.15%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ABOS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc

Average user rating I10

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

The Company Acumen Pharmaceuticals Inc (United States), is listed on Nasdaq with a market value of $ 113.46 Millions, having an equity of $ 93.17 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -133.35 Millions.

As for its main indicators, the Company has a P/E ratio of -0.85, a P/BV ratio of 1.22 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ABOS.

Market cap

$ 113.46 Millions

Net worth

$ 93.17 Millions

US$ 93,170,000.00

Assets

$ 142.22 Millions

US$ 142,220,000.00

Total Shares Outstanding

61.00 Millions

61,000,000

Average Daily Trading Volume

$ 337.27 Thousand

US$ 337,272.00

Sector

Others

Industry

Others

ABOS

ABOS revenue and profits

Financial Results ABOS

DRAG THE FRAME TO SEE MORE DATA

ABOS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

VET - Vermilion Energy Inc.

$ 8.60 0,10% (12M)

P/E

-0.38

4.04%

ABOS

Acumen Pharmaceuticals Inc

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of ABOS

review the fundamentals of Acumen Pharmaceuticals Inc shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc

United States

- year

-

Financial Results ABOS

ABOS cash flow

asset growth - ABOS

ABOS balance sheet

VET - Vermilion Energy Inc.

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

CRERF - Carrefour SA

VET - Vermilion Energy Inc.

UNH - UnitedHealth Group Incorporated

STLA - Stellantis NV

COR - Cencora Inc.

SSL - Sasol Ltd

SHEL - Shell PLC ADR

SSNLF - Samsung Electronics Co Ltd

CRERF - Carrefour SA

Frequently Asked Questions